Search research articles
Contact Us
Filters
Showing results (31-40 of 192) with videos related to
Page
of 20
Sort By:
Reviews on Recent Clinical Trials
|
January 28, 2016
Alcoholic Liver Disease and Hepatitis C Chronic Infection
Alessandro Federico, Marcello Dallio, Vittorio M Ormando, et al.
Expert Review of Clinical Pharmacology
|
September 1, 2022
BNT162b2 mRNA COVID-19 vaccine is safe in a setting of patients on biologic therapy with inflammatory bowel diseases: a monocentric real-life study
Raffaele Pellegrino, Gianluca Pellino, Lucio Selvaggi, et al.
Reviews on Recent Clinical Trials
|
July 30, 2024
Vanek's Tumour as a Rare Cause of Dyspeptic Syndrome in a Patient with Primary Biliary Cholangitis: A Case Report
Antonietta Gerarda Gravina, Raffaele Pellegrino, Mario Romeo, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 3, 2014
New silibinin glyco-conjugates: synthesis and evaluation of antioxidant properties
Armando Zarrelli, Valeria Romanucci, Concetta Tuccillo, et al.
Clinics in Dermatology
|
September 14, 2021
Are dissecting cellulitis and hidradenitis suppurativa different diseases?
Alessandro Federico, Alfredo Rossi, Gemma Caro, et al.
World Journal of Gastroenterology
|
December 11, 2014
Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease
Alessandro Federico, Claudio Zulli, Ilario de Sio, et al.
World Journal of Gastroenterology
|
October 13, 2010
Fat: a matter of disturbance for the immune system
Alessandro Federico, Elena D'Aiuto, Francesco Borriello, et al.
International Journal of Environmental Research and Public Health
|
August 24, 2019
Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way
Ludovico Abenavoli, Luigi Boccuto, Alessandro Federico, et al.
World Journal of Gastrointestinal Endoscopy
|
December 30, 2024
Water-assisted colonoscopy in inflammatory bowel diseases: From technical implications to diagnostic and therapeutic potentials
Raffaele Pellegrino, Giovanna Palladino, Michele Izzo, et al.
Frontiers in Medicine
|
October 25, 2021
PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled Trial
Marcello Dallio, Mario Masarone, Mario Romeo, et al.
Page
of 20
Search research articles
Search
Showing results (31-40 of 192) with videos related to
Sort By:
Page
of 20
Reviews on Recent Clinical Trials
|
January 28, 2016
Alcoholic Liver Disease and Hepatitis C Chronic Infection
Alessandro Federico, Marcello Dallio, Vittorio M Ormando, et al.
Expert Review of Clinical Pharmacology
|
September 1, 2022
BNT162b2 mRNA COVID-19 vaccine is safe in a setting of patients on biologic therapy with inflammatory bowel diseases: a monocentric real-life study
Raffaele Pellegrino, Gianluca Pellino, Lucio Selvaggi, et al.
Reviews on Recent Clinical Trials
|
July 30, 2024
Vanek's Tumour as a Rare Cause of Dyspeptic Syndrome in a Patient with Primary Biliary Cholangitis: A Case Report
Antonietta Gerarda Gravina, Raffaele Pellegrino, Mario Romeo, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 3, 2014
New silibinin glyco-conjugates: synthesis and evaluation of antioxidant properties
Armando Zarrelli, Valeria Romanucci, Concetta Tuccillo, et al.
Clinics in Dermatology
|
September 14, 2021
Are dissecting cellulitis and hidradenitis suppurativa different diseases?
Alessandro Federico, Alfredo Rossi, Gemma Caro, et al.
World Journal of Gastroenterology
|
December 11, 2014
Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease
Alessandro Federico, Claudio Zulli, Ilario de Sio, et al.
World Journal of Gastroenterology
|
October 13, 2010
Fat: a matter of disturbance for the immune system
Alessandro Federico, Elena D'Aiuto, Francesco Borriello, et al.
International Journal of Environmental Research and Public Health
|
August 24, 2019
Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way
Ludovico Abenavoli, Luigi Boccuto, Alessandro Federico, et al.
World Journal of Gastrointestinal Endoscopy
|
December 30, 2024
Water-assisted colonoscopy in inflammatory bowel diseases: From technical implications to diagnostic and therapeutic potentials
Raffaele Pellegrino, Giovanna Palladino, Michele Izzo, et al.
Frontiers in Medicine
|
October 25, 2021
PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled Trial
Marcello Dallio, Mario Masarone, Mario Romeo, et al.
Page
of 20